Den här översättningen är inte klar ännu. Den här sidan är just nu på engelska.

Gå till den engelska sidan

Can a 3-Week boot camp restore arm function after stroke?

NCT ID NCT05689502

What the study statuses mean

This study's is highlighted.

Recruitment status, easiest to join first

Recruiting now
This trial is taking on new participants right now.
Not yet recruiting
Registered, but not yet taking participants.
By invitation only
Not open to general applications. Only people the study team invites can take part.
Paused
Paused for now. It may or may not start again.
Ongoing This study
Running, but no longer taking on new participants.
Completed
The trial has finished. Results may not be published yet.
Stopped early
Stopped early, before it reached the end. That can be for many reasons, including safety.
Cancelled
Cancelled before anyone took part.

Expanded access (not trials)

Expanded access
Not a trial. This treatment can be requested outside a study, case by case, for people who qualify.
Expanded access (paused)
Not a trial. The treatment can normally be requested outside a study, but is unavailable right now.
Expanded access (ended)
Not a trial. The treatment could once be requested outside a study, but no longer can.
Approved
The treatment has been approved, so it is available normally rather than through this programme.

When the status isn't known

Details not published
The full record has not been published yet, so there is little to show here.
Status unknown
This status has not been confirmed recently, so it may be out of date.

First seen Jun 25, 2026 · Last updated Jun 27, 2026 · Updated 1 time

Summary

This study tests whether a high-dose, intensive therapy program can improve arm movement and quality of life in people who had a stroke at least 6 months ago. Nine participants will receive 6 hours of therapy per day, 5 days a week, for 3 weeks, including occupational and physical therapy. The goal is to see if this approach is feasible and leads to meaningful improvements.

What this could mean

Our plain-language read of the trial. This is informational only, not medical advice or a prediction.

Active substance
intensive upper extremity therapy program (occupational therapy, physical therapy, guided individual work, and optional electrical stimulation)
What this could lead to
If successful, this could show that a short, intensive therapy program improves arm function and quality of life for chronic stroke survivors.
What could go wrong
This is a very small feasibility study with only 9 participants, so results may not apply to everyone. The therapy is demanding (6 hours/day) and may be hard to tolerate.

This is an AI summary of the original study and may miss details. Read our disclaimer.

Study facts

What this study's own registry entry says, in plain language.

Phase

Not a phased trial

Phase numbers describe drug development. The registry uses this when they do not apply, as it does for trials of devices, procedures or behaviour changes, and for observational studies.

Participants

About 9 people

The number the study aims to enrol. It can still change while the study runs.

Started

Mar 2023

Expected to finish

Dec 2026

An estimate. End dates often move.

Lead sponsor

Other sponsor

The registry's catch-all category, for sponsors it does not file as a company, a government agency, or a research network.

Who can take part

This study's own entry requirements. Only the study team can say for certain whether you qualify.

Ages

18 to 80 years

Sex

Anyone

Healthy volunteers

Not accepted

This study is not open to healthy volunteers. The entry requirements below say who it is open to.

Show the full entry requirements

Copied word for word from the study's registry entry, so the wording is the study team's rather than ours.

Inclusion Criteria: * Single qualifying stroke event as confirmed by CT or MRI * At least 6 months post stroke * Fugl-Meyer upper extremity (UE) score of 20-45 * Able to follow written instructions * Able to tolerate 6 hours of therapy a day Exclusion Criteria: * Prior arm injury impacting available passive or active range of motion or significant arm pain with movement * Active drug or alcohol abuse * Diagnosed with advanced dementia * Pre-stroke baseline mRS\>3 * History of clinically significant ischemic or hemorrhagic stroke resulting in prior arm weakness in the same territory as the index stroke * Medical instability assessed by the treating stroke physician to participate to the study.

Get updates

Get notified about this study

Sign up to get updates when this study changes or when new studies for Chronic stroke are added.

Vår säkerhetsrekommendation!

Genom att skicka in godkänner du våra Användarvillkor

Conditions

The condition(s) this trial relates to.

As listed by the trial registrant

The condition terms exactly as the trial's registrant entered them.

Contacts and locations

Locations

  • The University of Texas Health Science Center at Houston

    Houston, Texas, 77030, United States

More trials for these conditions

Other studies related to the condition(s) this trial covers.